Natalizumab and Ocrelizumab: Drug Interaction Guide

Quick answer: This is a major interaction — avoid combining Natalizumab and Ocrelizumab unless specifically directed by your doctor.

Interaction severity: Major — avoid combination

How Natalizumab interacts with Ocrelizumab

Both agents suppress immune function through different pathways, increasing risk of serious infections including progressive multifocal leukoencephalopathy. Overlapping biologic immunosuppression increases cumulative risk.

What you should do

Avoid concurrent use. Use specialist-directed washout and risk assessment when switching disease-modifying therapy.

Key facts

Severity

Major — avoid combination

Mechanism

Both agents suppress immune function through different pathways, increasing risk of serious infections including progres...

Action

Avoid concurrent use. Use specialist-directed washout and risk assessment when switching disease-modifying therapy.

Important medical disclaimer: This page provides educational information about drug interactions for general reference. It is not a substitute for professional medical advice, diagnosis, or treatment. Always discuss your specific medications with a qualified healthcare provider before starting, stopping, or changing any treatment. About our editorial team.

Frequently asked questions

Can I take Natalizumab and Ocrelizumab together?

No — this combination should generally be avoided. Avoid concurrent use. Use specialist-directed washout and risk assessment when switching disease-modifying therapy.

What is the severity of this interaction?

The interaction between Natalizumab and Ocrelizumab is classified as Major — avoid combination. Both agents suppress immune function through different pathways, increasing risk of serious infections including progressive multifocal leukoencephalopathy. Overlapping biologic immunosuppression increases cumulative risk.

What should I do if I'm prescribed both?

Avoid concurrent use. Use specialist-directed washout and risk assessment when switching disease-modifying therapy. Always consult your prescribing clinician — do not stop or change medications without medical guidance.

Last reviewed: by iMedic Medical Editorial Team. Our editorial process.